NUTX vs. DAVE
NUTX (Nutex Health Inc) and DAVE (Dave Inc.) are both stocks. NUTX operates in Health Information Services (Healthcare), while DAVE operates in Credit Services (Financial Services). Over the past 3 years, NUTX returned 34.96%/yr vs 285.61%/yr for DAVE. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
NUTX vs. DAVE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUTX achieves a -10.44% return, which is significantly lower than DAVE's 68.33% return.
NUTX
- 1D
- -0.86%
- 1M
- -24.98%
- 6M
- -0.91%
- YTD
- -10.44%
- 1Y
- 75.51%
- 3Y*
- 34.96%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -42.12%
DAVE
- 1D
- -1.31%
- 1M
- -3.79%
- 6M
- 127.68%
- YTD
- 68.33%
- 1Y
- 60.14%
- 3Y*
- 285.61%
- 5Y*
- 3.39%
- 10Y*
- —
- ALL TIME*
- 3.33%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
DAVE Dave Inc. | $172.88M | $187.81M | $183.81M |
NUTX Nutex Health Inc | $17.86M | $21.25M | $20.00M |
NUTX vs. DAVE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NUTX Nutex Health Inc | -10.44% | 419.47% | 17.37% | -90.53% | -81.82% |
DAVE Dave Inc. | 68.33% | 154.73% | 936.61% | -9.64% | -95.75% |
Correlation
The correlation between NUTX and DAVE is 0.34, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.34 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Apr 4, 2022 | 0.19 |
The correlation between NUTX and DAVE shifts across timeframes, from 0.18 (3 years) to 0.34 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
NUTX:
$1.01B
DAVE:
$5.01B
NUTX:
$20.14
DAVE:
$15.57
NUTX:
7.32
DAVE:
23.94
NUTX:
0.06
DAVE:
0.11
NUTX:
0.80
DAVE:
9.77
NUTX:
$879.95M
DAVE:
$551.52M
NUTX:
$417.67M
DAVE:
$427.68M
NUTX:
$275.94M
DAVE:
$165.95M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUTX vs. DAVE — Risk / Return Rank
NUTX
DAVE
NUTX vs. DAVE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and Dave Inc. (DAVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUTX | DAVE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.03 | ||
| Sortino ratioReturn per unit of downside risk | +0.12 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.19 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.37 | 1.49 | -0.13 |
| Martin ratioReturn relative to average drawdown | 2.68 | 3.26 | -0.57 |
Loading charts...
Drawdowns
NUTX vs. DAVE - Drawdown Comparison
The maximum NUTX drawdown since its inception was -99.93%, roughly equal to the maximum DAVE drawdown of -99.01%. Use the drawdown chart below to compare losses from any high point for NUTX and DAVE.
Loading charts...
Drawdown Indicators
| NUTX | DAVE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.93% | -99.01% | -0.92% |
Max Drawdown (1Y)Largest decline over 1 year | -54.32% | -39.11% | -15.21% |
Max Drawdown (3Y)Largest decline over 3 years | -92.39% | -44.67% | -47.72% |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.01% | — |
Current DrawdownCurrent decline from peak | -97.54% | -18.56% | -78.98% |
Average DrawdownAverage peak-to-trough decline | -97.19% | -67.63% | -29.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.59% | 17.88% | +9.71% |
Volatility
NUTX vs. DAVE - Volatility Comparison
Nutex Health Inc (NUTX) has a higher volatility of 15.79% compared to Dave Inc. (DAVE) at 14.54%. This indicates that NUTX's price experiences larger fluctuations and is considered to be riskier than DAVE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUTX | DAVE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.79% | 14.54% | +1.25% |
Volatility (6M)Calculated over the trailing 6-month period | 60.57% | 48.39% | +12.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.11% | 69.38% | +21.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 189.30% | 99.00% | +90.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 189.30% | 96.44% | +92.86% |
Dividends
NUTX vs. DAVE - Dividend Comparison
Neither NUTX nor DAVE has paid dividends to shareholders.
Financials
NUTX vs. DAVE - Financials Comparison
This section allows you to compare key financial metrics between Nutex Health Inc and Dave Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NUTX vs. DAVE - Profitability Comparison
NUTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nutex Health Inc reported a gross profit of 91.73M and revenue of 216.49M. Therefore, the gross margin over that period was 42.4%.
DAVE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Dave Inc. reported a gross profit of 120.00M and revenue of 147.59M. Therefore, the gross margin over that period was 81.3%.
NUTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nutex Health Inc reported an operating income of 81.27M and revenue of 216.49M, resulting in an operating margin of 37.5%.
DAVE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Dave Inc. reported an operating income of 21.15M and revenue of 147.59M, resulting in an operating margin of 14.3%.
NUTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nutex Health Inc reported a net income of 46.81M and revenue of 216.49M, resulting in a net margin of 21.6%.
DAVE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Dave Inc. reported a net income of 57.94M and revenue of 147.59M, resulting in a net margin of 39.3%.
Frequently Asked Questions
NUTX and DAVE have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NUTX has higher volatility (15.79%) compared to DAVE (14.54%). In terms of maximum drawdown, NUTX dropped -99.93% vs DAVE's -99.01%.
DAVE currently has the higher Sharpe Ratio (0.84 vs 0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUTX and DAVE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer